Lupin informs about press release

20 Oct 2022 Evaluate

Lupin has informed that Lupin Inc., USA, wholly owned subsidiary of the Company, has signed Definitive Agreement with Sunovion Pharmaceuticals Inc., USA for acquiring Brovana® and Xopenex HFA®, respiratory brands. In this regard, in compliance with Regulation 30 read with Schedule III of the Listing Regulations and SEBI Circular CIR/CFD/CMD/4/2015 dated September 9, 2015, the company has attached some particulars. It had also attached a Press Release in connection with the acquisition.

The above information is a part of company’s filings submitted to BSE.

Lupin Share Price

2322.45 68.55 (3.04%)
20-Mar-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1777.45
Dr. Reddys Lab 1298.95
Cipla 1255.85
Zydus Lifesciences 890.60
Lupin 2322.45
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×